6 results
6-K
EX-99.1
BLU
Bellus Health Inc
28 Jun 23
GSK completes acquisition of BELLUS Health
11:05am
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
and talented executives in our industry is extremely competitive and we compete for talent with many companies that have greater resources than we do … or level. The Company believes equity-based compensation is a critical tool to secure and retain talent. Additionally, the longer vesting periods
6-K
EX-99.1
BLU
Bellus Health Inc
16 May 23
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
5:04pm
to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com/company.
About the Purchaser
The Purchaser
6-K
EX-99.1
BLU
Bellus Health Inc
18 Apr 23
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
6:02am
is not currently approved anywhere in the world.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
for qualified and talented executives in our industry is extremely competitive and we compete for talent with many companies that have greater resources … compensation is a critical tool to secure and retain talent. Additionally, the longer vesting periods for equity awards relative to many peers aim to retain
6-K
EX-99.2
u5zrn7qcvf8
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
- Prev
- 1
- Next